-
公开(公告)号:US20120172293A1
公开(公告)日:2012-07-05
申请号:US13381737
申请日:2010-07-01
申请人: Taiji Asami , Naoki Nishizawa , Ayumu Niida , Yusuke Adachi
发明人: Taiji Asami , Naoki Nishizawa , Ayumu Niida , Yusuke Adachi
CPC分类号: C07K14/575 , A61K38/00
摘要: The present invention aims to provide a peptide having a superior Y2 receptor agonist action and useful as an agent for the prophylaxis or treatment of obesity and the like.A peptide represented by the formula: P1-X1-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-NH2 wherein each symbol is as described in the specification, or a salt thereof.
摘要翻译: 本发明的目的在于提供具有优异的Y2受体激动剂作用的肽,可用作预防或治疗肥胖症等的药剂。 由式:P1-X1-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-NH2表示的肽,其中每个符号如说明书中所述,或其盐 。
-
公开(公告)号:US08183212B2
公开(公告)日:2012-05-22
申请号:US12298200
申请日:2006-10-24
申请人: Nobutaka Fujii , Shinya Oishi , Kenji Tomita , Ayumu Niida
发明人: Nobutaka Fujii , Shinya Oishi , Kenji Tomita , Ayumu Niida
CPC分类号: C07K5/0808 , A61K38/00 , C07K7/06
摘要: The present invention provides a compound represented by the following formula (1); wherein R1 is an aryl group etc.; R2 is —CO—NH— etc.; R3 is a methyl group having an aromatic group or a cycloalkyl group; R4 is a hydrogen atom etc.; R5 is a methyl group having an aromatic group; and R6 is an amino group or an N-alkyl substituted amino group, having a low-molecular weight and a superior GPR54 agonist activity, and a pharmaceutical composition containing the compound.
摘要翻译: 本发明提供由下式(1)表示的化合物。 其中R1是芳基等; R2是-CO-NH-等; R3是具有芳基或环烷基的甲基; R4是氢原子等。 R5是具有芳基的甲基; 和R6是具有低分子量和优异的GPR54激动剂活性的氨基或N-烷基取代的氨基,以及含有该化合物的药物组合物。
-
公开(公告)号:US09260500B2
公开(公告)日:2016-02-16
申请号:US13381737
申请日:2010-07-01
申请人: Taiji Asami , Naoki Nishizawa , Ayumu Niida , Yusuke Adachi
发明人: Taiji Asami , Naoki Nishizawa , Ayumu Niida , Yusuke Adachi
IPC分类号: A61K38/10 , A61P3/04 , C07K7/08 , C07K14/575 , A61K38/00
CPC分类号: C07K14/575 , A61K38/00
摘要: The present invention aims to provide a peptide having a superior Y2 receptor agonist action and useful as an agent for the prophylaxis or treatment of obesity and the like.A peptide represented by the formula: P1—X1-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-NH2 wherein each symbol is as described in the specification, or a salt thereof.
摘要翻译: 本发明的目的在于提供具有优异的Y2受体激动剂作用的肽,可用作预防或治疗肥胖症等的药剂。 由式:P1-X1-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-NH2表示的肽,其中每个符号如说明书中所述,或其盐 。
-
公开(公告)号:US20100160241A1
公开(公告)日:2010-06-24
申请号:US12298200
申请日:2006-10-24
申请人: Nobutaka Fujii , Shinya Oishi , Kenji Tomita , Ayumu Niida
发明人: Nobutaka Fujii , Shinya Oishi , Kenji Tomita , Ayumu Niida
CPC分类号: C07K5/0808 , A61K38/00 , C07K7/06
摘要: The present invention provides a compound represented by the following formula (1); wherein R1 is an aryl group etc.; R2 is —CO—NH— etc.; R3 is a methyl group having an aromatic group or a cycloalkyl group; R4 is a hydrogen atom etc.; R5 is a methyl group having an aromatic group; and R6 is an amino group or an N-alkyl substituted amino group, having a low-molecular weight and a superior GPR54 agonist activity, and a pharmaceutical composition containing the compound.
摘要翻译: 本发明提供由下式(1)表示的化合物。 其中R1是芳基等; R2是-CO-NH-等; R3是具有芳基或环烷基的甲基; R4是氢原子等。 R5是具有芳基的甲基; 和R6是具有低分子量和优异的GPR54激动剂活性的氨基或N-烷基取代的氨基,以及含有该化合物的药物组合物。
-
-
-